SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021089
Filing Date
2024-08-12
Accepted
2024-08-12 16:40:20
Documents
1
Period of Report
2024-08-08

Document Format Files

Seq Description Document Type Size
1 form4-08122024_080817.html 4  
1 form4-08122024_080817.xml 4 6611
  Complete submission text file 0001415889-24-021089.txt   8137
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SIERRA ONCOLOGY, INC. 1820 GATEWAY DRIVE, SUITE 110 SAN MATEO CA 94404
Business Address
Jagpal Sukhi (Reporting) CIK: 0001554591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 241197466